Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In this prospective cohort study, the investigators aim to investigate the incidence of ICM-detected AF in unselected ischemic stroke patients and its association with anticoagulation initiation and stroke recurrence.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 100
Healthy Volunteers: f
View:
• Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
• Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
• Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
• Informed consent for participation in the study will be obtained from the patients or guardians of patients.
Locations
Other Locations
Greece
Second Department of Neurology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
RECRUITING
Athens
Time Frame
Start Date: 2023-05-05
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 200
Treatments
Experimental: implantable cardiac monitoring device (Reveal LINQTM)
All included patients will have long-term heart rate monitors (Reveal LINQ; Medtronic)
Related Therapeutic Areas
Sponsors
Leads: National and Kapodistrian University of Athens